SD Dengue Duo NS1 Ag and IgG/IgM test |
|
11FK45 |
Abbott |
10 tests/kit |
EUR 147.4 |
Human IgG antibody Laboratories manufactures the expedion ag reagents distributed by Genprice. The Expedion Ag reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Expedeon. Other Expedion products are available in stock. Specificity: Expedion Category: Ag
Mouse True Insulin Antigen(TI-Ag) ELISA Kit |
|
Enlibio |
each |
EUR 480 |
Porcine True Insulin Antigen(TI-Ag) ELISA Kit |
|
Enlibio |
each |
EUR 520 |
Rat True Insulin Antigen(TI-Ag) ELISA Kit |
|
Enlibio |
each |
EUR 480 |
Rabbit True Insulin Antigen(TI-Ag) ELISA Kit |
|
Enlibio |
each |
EUR 520 |
Rat True Insulin Antigen (TI-Ag) ELISA Kit |
|
MyBiosource |
10x96-Strip-Wells |
EUR 3290 |
Rat True Insulin Antigen (TI-Ag) ELISA Kit |
|
MyBiosource |
48-Strip-Wells |
EUR 295 |
Rat True Insulin Antigen (TI-Ag) ELISA Kit |
|
MyBiosource |
5x96-Strip-Wells |
EUR 1800 |
Serum / Plasma information
AG-14361 |
|
27602-1 |
BPS Bioscience |
5 mg |
EUR 205 |
|
Description: AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides. AG14361 treatment before irradiation statistically significantly increases the sensitivity to radiation therapy. AG14361 enhances the growth-inhibitory and cytotoxic effects of topoisomerase I poisons and increases the persistence of camptothecin-induced DNA single-strand breaks. |
AG-14361 |
|
27602-2 |
BPS Bioscience |
10 mg |
EUR 360 |
|
Description: AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides. AG14361 treatment before irradiation statistically significantly increases the sensitivity to radiation therapy. AG14361 enhances the growth-inhibitory and cytotoxic effects of topoisomerase I poisons and increases the persistence of camptothecin-induced DNA single-strand breaks. |
AG-14361 |
|
27602-3 |
BPS Bioscience |
50 mg |
EUR 825 |
|
Description: AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides. AG14361 treatment before irradiation statistically significantly increases the sensitivity to radiation therapy. AG14361 enhances the growth-inhibitory and cytotoxic effects of topoisomerase I poisons and increases the persistence of camptothecin-induced DNA single-strand breaks. |
AG 494 |
|
20-abx076583 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
AG-494 |
|
abx076583-20rxns |
Abbexa |
20 rxns |
EUR 118.75 |
AG-494 |
|
abx076583-60rxns |
Abbexa |
60 rxns |
EUR 287.5 |
AG-490 |
|
abx076686-10rxns |
Abbexa |
10 rxns |
EUR 118.75 |
AG-879 |
|
abx076726-100l |
Abbexa |
100 µl |
EUR 143.75 |
AG-879 |
|
abx076726-1ml |
Abbexa |
1 ml |
Ask for price |
AG-879 |
|
abx076726-200l |
Abbexa |
200 µl |
EUR 375 |
